35520 Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices 

(2) develops and applies spatial analytic 

and small area estimation methods to 

identify geographic variations in 

chronic disease conditions and related 

risk factors for public health 

programming and decision making; (3) 

provides public health leadership in the 

prevention of excessive alcohol use and 

other chronic disease risk factors 

through public health surveillance, 

partnerships, and applied research for 

translation into public health practice; 

(4) provides public health leadership for 

epilepsy and other chronic conditions 

with significant impact on quality of life 

through surveillance and epidemiologic 

research, partnerships, applied research 

and translation, and development and 

evaluation of programs and 

interventions in order to expand the 

reach of evidence-based programs and 

practices and improve quality of life; 

and (5) conducts strategic and 

innovative scientific research on lupus 

and other evolving and cross-cutting 

disease issues including determining 

the burden, developing pilot programs 

and assessing effectiveness of public 

health approaches, and works with 

national, state and local partners to 

increase awareness, advance knowledge, 

and inform public health and health 

care practice. 

Healthy Schools Branch (CUCPG) (1) 

Supports state, local, territorial, and 

tribal agencies and national nongovernmental organizations to develop, 

implement, evaluate, and disseminate 

school policy, systems, and 

environmental strategies and 

interventions to improve the health of 

students and school staff by promoting 

healthy eating, physical activity, and a 

tobacco-free lifestyle; (2) supports 

implementation and evaluation of a 

coordinated approach to school health 

and best practices in health education; 

physical education and other physical 

activity programs; nutrition services; 

school health services; school 

counseling, psychological, and social 

services; health promotion for staff; 

family and community involvement; 

and school health and safety policies 

and environment; (3) provides 

leadership and consultation on how 

schools work and how to foster effective 

collaboration between the public health 

and education sectors; (4) documents 

and strengthens the scientific 

associations among chronic diseaserelated health risks, school-based health 

promotion initiatives, and academic 

achievement; (5) evaluates school-based 

policy, systems, and environmental 

changes and interventions to improve 

health behaviors and reduce chronic 

disease-related health risks among 

children and adolescents; (6) 

synthesizes and translates scientific 

research to develop and disseminate 

guidance, tools, and resources to help 

schools prevent chronic disease-related 

risks among children and adolescents; 

(7) supports efforts of national, state, 

and local surveillance systems to 

monitor chronic disease-related health 

risk behaviors among youth, along with 

the policies, programs, and practices 

schools implement to address those 

health risk behaviors; (8) strengthens 

efforts of national, state, and local 

programs to provide high quality 

professional development services to 

support school-based chronic disease 

prevention policies, programs, and 

practices; (9) in accomplishing the 

functions listed above, collaborates with 

other components of CDC and HHS; the 

U.S. Department of Education, U.S. 

Department of Agriculture, and other 

federal agencies; national professional, 

voluntary, and philanthropic 

organizations; international agencies; 

and other organizations as appropriate; 

and(10) assists other nations in reducing 

chronic disease-related health risks 

among children and adolescents and in 

implementing and improving school 

health programs. 

Population Health Surveillance 

Branch (CUCPH). (1) Plans and directs 

all activities related to the Behavioral 

Risk Factor Surveillance System 

(BRFSS), the nation’s premier system of 

health surveys that collect state data 

about United States residents regarding 

their health-related risk behaviors, 

chronic health conditions, and use of 

preventive services; (2) coordinates 

BRFSS surveillance activities across all 

states and CDC programs; (3) provides 

support to build state capacity for 

BRFSS survey operations, data 

management, analysis, dissemination, 

and use of the data by state agencies to 

set public health priorities and monitor 

public health programs; (4) develops 

guidelines and criteria for the 

enhancement of behavioral risk factor 

surveys at the state and local levels; (5) 

delivers timely health data of high 

validity and reliability to states, CDC 

scientists, the national public health 

community, and the general public; (6) 

supports and enhances analysis and 

dissemination of information from the 

BRFSS to promote the broad use and 

application of BRFSS results and 

findings by policy and decision makers, 

public health professionals, and other 

relevant audiences through 

communication channels and formats 

appropriate to these constituencies; (7) 

plans and coordinates cross cutting 

research related to survey methodology; 

(8) provides scientific leadership and 

guidance to surveillance programs to 

assure highest scientific quality and 

professional standards related to BRFSS; 

(9) provides leadership to CDC, states 

and other organizations to support 

effective and flexible population health 

surveillance, including rapidly 

emerging public health issues and 

threats; and (10) provides administrative 

and management support, as required, 

for states and territories including 

oversight of BRFSS and other grants, 

cooperative agreements, and 

reimbursable agreements. 

Retitle HIV Surveillance (CVJCE) to 

HIV Surveillance Branch. 

Retitle HIV Prevention Capacity and 

Development Branch (CVJCH) to HIV 

Prevention Capacity Development 

Branch. 

Dia Taylor, 

Chief Operating Officer (Acting), Centers for 

Disease Control and Prevention. 

[FR Doc. 2021–14341 Filed 7–2–21; 8:45 am] 

BILLING CODE 4160–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Community Living 

Reallotment of FY 2021 Funds: Puerto 

Rico 

AGENCY: Administration on Disabilities 

(AoD), Administration for Community 

Living (ACL), U.S. Department of Health 

and Human Services (HHS). 

ACTION: Notice of reallotment of FY 2021 

funds. 

SUMMARY: The Administration on 

Disabilities (AoD) intends to reallot 

funds under the authority of the 

Development Disabilities Assistance 

and Bill of Rights Act of 2000 which 

states: ‘‘If the Secretary determines that 

an amount of an allotment to a State for 

a period (of a fiscal year or longer) will 

not be required by the State during the 

period for the purpose for which the 

allotment was made, the Secretary may 

reallot the amount.’’ 

DATES: Funds will be realloted after 

August 13, 2021 and before September 

30, 2021. 

FOR FURTHER INFORMATION CONTACT: 

Allison Cruz, Office of Intellectual and 

Developmental Disabilities, 

Administration on Disabilities, 

Administration for Community Living, 

330 C St. SW, Washington, DC 20201. 

Telephone (202) 795–7408. Email 

allison.cruz@acl.hhs.gov. Please note 

the telephone number is not toll free. 

This document will be made available 

in alternative formats upon request. 


jbell on DSKJLSW7X2PROD with NOTICES
Federal Register / Vol. 86, No. 126 / Tuesday, July 6, 2021 / Notices 35521 

Written correspondence can be sent to 

Administration for Community Living, 

U.S. Department of Health and Human 

Services, 330 C St. SW, Washington, DC 

20201. 

SUPPLEMENTARY INFORMATION: AoD will 

be reallotting FY 2021 funds awarded to 

the State Council on Developmental 

Disabilities (SCDD) located within the 

Commonwealth of Puerto Rico. This 

determination is based on the limited 

reported expenditures and requests for 

reimbursement over the last several 

years from the SCDD in the 

Commonwealth of Puerto Rico. 

The Puerto Rico SCDD will have up 

to $1.8 million rescinded and 

proportionately redistributed to the 

remaining SCDDs. SCDDs that receive 

FY 2021 realloted funds will have 

through the end of FY 2022 to obligate 

the funds and until the end of FY 2023 

to liquidate the funds. Realloted funds 

for the SCDDs must be used according 

to the terms as outlined in the FY 2021 

Notice of Award for each program. 

Jennifer G. Johnson, 

Deputy Commissioner, Administration on 

Disabilities. 

[FR Doc. 2021–14314 Filed 7–2–21; 8:45 am] 

BILLING CODE 4154–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Integrative Health 

Special Emphasis Panel; Center of Excellence 

for Research on Complementary and 

Integrative Health (P01) (CERCIH). 

Date: July 30, 2021. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Complementary 

and Integrative Democracy, 6707 Democracy 

Blvd., Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Martina Schmidt, Ph.D., 

Chief Office of Scientific Review, National 

Center for Complementary & Integrative 

Health, NIH, 6707 Democracy Blvd., Suite 

401, Bethesda, MD 20892, 301–594–3456, 

schmidma@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 

in Complementary and Alternative Medicine, 

National Institutes of Health, HHS) 

Dated: June 29, 2021. 

Tyeshia M. Roberson-Curtis, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–14281 Filed 7–2–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Platelets 

and Red Blood Cells. 

Date: July 14, 2021. 

Time: 11:00 a.m. to 1:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Ai-Ping Zou, MD, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4118, 

MSC 7814, Bethesda, MD 20892, 301–408– 

9497, zouai@csr.nih.gov. 

This notice is being published less than 15 

days prior to the meeting due to the timing 

limitations imposed by the review and 

funding cycle. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

conflict: Topics in Adult Psychopathology. 

Date: July 30, 2021. 

Time: 1:00 p.m. to 6:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Rockledge II, 6701 Rockledge Drive, 

Bethesda, MD 20892 (Virtual Meeting). 

Contact Person: Alyssa Todaro Brooks, 

Ph.D., Scientific Review Officer, Center for 

Scientific Review, National Institute of 

Health, 6701 Rockledge Drive, Room 1000F, 

Bethesda, MD 20892, (301) 827–9299, 

brooksaly@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: June 29, 2021. 

David W. Freeman, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2021–14279 Filed 7–2–21; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Center for Complementary & 

Integrative Health; Notice of Closed 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Center for 

Complementary and Integrative Health 

Special Emphasis Panel; Exploratory Clinical 

Trials of Mind and Body Interventions (MB). 

Date: July 29, 2021. 

Time: 12:00 p.m. to 3:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Center for Complementary 

and Integrative, Democracy II, 6707 

Democracy Blvd., Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: SUSHMITA Purkayastha, 

Ph.D., Scientific Review Officer, Office of 

Scientific Review, Division of Extramural 

Activities, NCCIH/NIH, 6707 Democracy 

Boulevard, Suite 401, Bethesda, MD 20892– 

5475 sushmita.purkayastha@nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.213, Research and Training 


jbell on DSKJLSW7X2PROD with NOTICES